Gensun Biopharma is a privately held biotechnology company that was established in 2016. Gensun specializes in the generation and engineering of biologics for the treatment of cancer. Gensun's robust pipeline includes molecules in pre-IND development and a number of molecules in early stages of development, all backed by strong intellectual property positions.